2026年8月19日 7:32 ET 发布 · 更新于 3 个月前 · 1 个来源
Oxford Nanopore CEO’s $1 Billion Sales Goal Sends Stock Soaring
bloomberg
·
原始报道
Oxford Nanopore Technologies Plc plans to focus on the most lucrative opportunities in gene sequencing, including quality control for mRNA vaccines, as it moves closer to break even in an increasingly competitive market.
原文